|
Real-time Estimate
Tradegate
12:54:25 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 30.10 EUR | +1.01% |
|
-5.70% | - |
| 08-04 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-04 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Stock exchange
Quotes 5-day view: Indivior Pharmaceuticals, Inc.
Delayed Quote Xetra| 26/08/2026 | 27/08/2026 | 28/08/2026 | 31/08/2026 | 01/09/2026 | |
|---|---|---|---|---|---|
| Last | €31.00 | €30.60 | €30.20 | €29.80 | €29.80 |
| Change | 0.00% | -1.29% | -1.31% | -1.32% | +1.01% |
Performance
| 1 week | -5.70% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
4,122,216,759
Market Cap (USD)
4,122,216,759
Net sales (USD)
1,239,000,000
Free-Float
97.98 %
Free-Float capitalization (EUR)
4,691,142,814
Free-Float capitalization (USD)
4,039,073,963
Indicators
Moving average 5 days
30.52
Moving average 20 days
31.4
Moving average 50 days
32.73
Price spread / (MMA5)
+1.40%
Price spread / (MMA20)
+4.32%
Price spread / (MMA50)
+8.73%
RSI 9 days
43.12
RSI 14 days
47.37
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.01% | -5.70% | - | - | 4.12B | ||
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | ||
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | ||
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | ||
| -1.87% | -6.99% | +32.40% | +32.35% | 349B | ||
| +4.44% | +1.20% | +26.33% | +43.63% | 290B | ||
| -1.32% | -2.63% | -0.49% | +10.60% | 252B | ||
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | ||
| +0.15% | -2.17% | -19.82% | -54.04% | 201B | ||
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | ||
| Average | -0.09% | -2.98% | +27.55% | +48.80% | 363.39B | |
| Weighted average by Cap. | -0.46% | -3.97% | +36.78% | +64.79% |
Historical Quotes: Indivior Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- INDV Stock
- E7P Stock
- Quotes Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

















